![Antibiotics | Free Full-Text | Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections Antibiotics | Free Full-Text | Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections](https://pub.mdpi-res.com/antibiotics/antibiotics-11-01528/article_deploy/html/images/antibiotics-11-01528-g001-550.jpg?1667560451)
Antibiotics | Free Full-Text | Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
![Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-007-0935-1/MediaObjects/134_2007_935_Fig1_HTML.gif)
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
![Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram](https://www.researchgate.net/profile/Stephan-Ehrmann/publication/5800487/figure/fig4/AS:277672988037128@1443213807809/Mean-cumulative-systemic-absorption-of-amikacin-as-a-function-of-time-Absorption-is_Q320.jpg)
Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram
![Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure - ScienceDirect Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221007030-gr1.jpg)
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure - ScienceDirect
![Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199319308331-gr1.jpg)
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
![Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/ff569ae1-c19e-4083-b5b9-6e1ae3175d03/gr2_lrg.jpg)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases
![Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.00011-18/asset/1c3c0b88-5f94-4150-aaff-531f6da0c2b7/assets/graphic/zac0061872290001.jpeg)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
![Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-007-0935-1/MediaObjects/134_2007_935_Fig3_HTML.gif)
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
![PDF) Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials PDF) Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials](https://i1.rgstatic.net/publication/350420208_Amikacin_nebulization_for_the_adjunctive_therapy_of_gram-negative_pneumonia_in_mechanically_ventilated_patients_a_systematic_review_and_meta-analysis_of_randomized_controlled_trials/links/605ecc4fa6fdccbfea0b5bee/largepreview.png)
PDF) Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
![Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/f5dc03e6-4b49-46a5-b7c6-340cfeeae82d/gr1_lrg.gif)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases
![A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP) | Ain-Shams Journal of Anesthesiology | Full Text A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP) | Ain-Shams Journal of Anesthesiology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs42077-020-00098-3/MediaObjects/42077_2020_98_Fig1_HTML.png)
A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP) | Ain-Shams Journal of Anesthesiology | Full Text
![PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)](https://mma.prnewswire.com/media/753414/Lamira_Nebulizer_System.jpg?p=facebook)
PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)
![A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4d4733837e341b5d1ab305032e835298a1e4d8c7/3-Figure1-1.png)
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar
![Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/154625/f/1.png)
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
![Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221002907-gr1.jpg)
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect
![Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia | Critical Care | Full Text Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia | Critical Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13054-023-04331-x/MediaObjects/13054_2023_4331_Fig3_HTML.png)
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia | Critical Care | Full Text
![Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-86342-8/MediaObjects/41598_2021_86342_Fig1_HTML.png)
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
![Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-86342-8/MediaObjects/41598_2021_86342_Fig2_HTML.png)
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
![The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here? | Journal of Aerosol Medicine and Pulmonary Drug Delivery The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here? | Journal of Aerosol Medicine and Pulmonary Drug Delivery](https://www.liebertpub.com/cms/10.1089/jamp.2021.0023/asset/images/medium/jamp.2021.0023_figure1.jpg)